Concord Hospital, Concord, New Hampshire,
J Am Psychiatr Nurses Assoc. 2009 Oct;15(5):325-32. doi: 10.1177/1078390309348653.
With the October 2008 Food and Drug Administration approval of repetitive transcranial magnetic stimulation (rTMS) for depression treatment, the establishment and administration of rTMS clinical treatment programs are critically important and emerging areas for psychiatric nursing leadership. There is growing recognition that many patients are unable to tolerate antidepressant medications and require alternative antidepressant treatment approaches. The enormous growth in the field of brain stimulation creates exciting new therapeutic options for patients with treatment-resistant depression. As with any clinical breakthrough, new treatments offer exciting possibilities but also require growth in psychiatric nursing knowledge, different practice competencies, and new ways of organizing care. This article discusses current practice guidelines, psychiatric nursing qualifications, and essential details about developing an rTMS clinical service. This is the first article to describe the role of a psychiatric nurse establishing a clinical rTMS service, administering rTMS, and helping patients undergo the treatment. The authors share the progress made and the lessons learned.
随着 2008 年 10 月食品和药物管理局批准重复经颅磁刺激(rTMS)用于抑郁症治疗,建立和管理 rTMS 临床治疗方案是精神科护理领导的关键和新兴领域。人们越来越认识到,许多患者无法耐受抗抑郁药物,需要替代抗抑郁治疗方法。脑刺激领域的巨大发展为治疗抵抗性抑郁症患者带来了令人兴奋的新治疗选择。与任何临床突破一样,新的治疗方法提供了令人兴奋的可能性,但也需要精神科护理知识、不同的实践能力和新的护理组织方式的增长。本文讨论了当前的实践指南、精神科护理资格以及关于开发 rTMS 临床服务的基本细节。这是第一篇描述精神科护士建立临床 rTMS 服务、管理 rTMS 和帮助患者接受治疗的角色的文章。作者分享了取得的进展和经验教训。